These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36272282)

  • 21. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant.
    Müller RH; Rühl D; Runge S; Schulze-Forster K; Mehnert W
    Pharm Res; 1997 Apr; 14(4):458-62. PubMed ID: 9144731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
    Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
    Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
    Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
    AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
    Luo Y; Teng Z; Li Y; Wang Q
    Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
    Yuan H; Miao J; Du YZ; You J; Hu FQ; Zeng S
    Int J Pharm; 2008 Feb; 348(1-2):137-45. PubMed ID: 17714896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
    Silva AC; González-Mira E; García ML; Egea MA; Fonseca J; Silva R; Santos D; Souto EB; Ferreira D
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):158-65. PubMed ID: 21530187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system.
    Limeres MJ; Suñé-Pou M; Prieto-Sánchez S; Moreno-Castro C; Nusblat AD; Hernández-Munain C; Castro GR; Suñé C; Suñé-Negre JM; Cuestas ML
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110533. PubMed ID: 31593829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
    Varia JK; Dodiya SS; Sawant KK
    Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
    Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
    Müller RH; Radtke M; Wissing SA
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
    Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
    Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
    Dasgupta S; Ghosh SK; Ray S; Mazumder B
    Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2406-17. PubMed ID: 21491451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration.
    Garcia-Fossa F; de Jesus MB
    Nanotoxicology; 2024 Feb; 18(1):36-54. PubMed ID: 38300021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
    Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
    J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
    Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations.
    Mosallaei N; Mahmoudi A; Ghandehari H; Yellepeddi VK; Jaafari MR; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2016 Jul; 104():42-50. PubMed ID: 27108266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production.
    Olbrich C; Schöler N; Tabatt K; Kayser O; Müller RH
    J Pharm Pharmacol; 2004 Jul; 56(7):883-91. PubMed ID: 15233867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.